Dementia and Alzheimer Disease

Neurology News Network for the week ending November 28, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 27, 2020.

The managing director of the Interdisciplinary Brain Center at Massachusetts General Hospital discussed the trial design and outcomes of the PEGASUS trial of AMX0035.

Stephen Cunnane, PhD, Research Center on Aging, Universite de Sherbrooke, discussed the findings and implications of a recent study of the drink’s effects on patients with mild cognitive impairment.

Ronald Crystal, MD, chairman, Department of Genetic Medicine, Weill Cornell Medicine, discussed the promise of gene therapy for patients with Alzheimer disease and related disorders.

Mayo Clinic's section edition book helps patients with Alzheimer disease and their caregivers answer questions as a guidance method.

The current study significantly increased the number of participants, allowing researchers to identify several new genetic risk factors for Alzheimer’s disease in African Americans.

The grant will allow for more confidence in risk genes and biological mechanisms that overlap among populations and will also allow for discovery and assessment of additional gene candidates that may be specific to certain populations.

Here's what is coming soon to NeurologyLive.

The professor from the Universite de Sherbrooke discusses the use of ketogenic diets and supplements to increase cognition.

Neurology News Network for the week ending November 21, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 20, 2020.

The professor from the Universite de Sherbrooke discusses the logistical hardships of trying to prescribe a diet as a method of treatment.

Recent studies of the CSF P-tau217 blood biomarker suggest it may help to simplify the diagnosis of Alzheimer disease.

The professor from the Universite de Sherbrooke also discusses other factors that increase cognitive decline in patients with MCI.

Frailty index score can identify patients at risk for cognitive dysfunction and might be an important marker with potential prognostic value.

The director of the Montefiore Einstein Center for the Aging Brain provided insight on how his studies may bring Alzheimer disease 1 step closer to prevention.

Women who did not work for pay post-childbearing represented the greatest later-life cognitive decline population in the first ever study that evaluated influence of work-family profiles.

Here's what is coming soon to NeurologyLive.

The professor from the Universite de Sherbrooke discusses how his recent study supports the concept of brain energy rescue.

The director of the Montefiore Einstein Center for the Aging Brain discussed the advantages of non-invasive brain stimulation and what has been previously observed in patients with Alzheimer disease.

Researchers will aim to create and validate a risk calculator and screening tool to identify and test individuals with high risk of cognitive decline.

Neurology News Network for the week ending November 14, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 13, 2020.

The study authors noted that dementia prevention could become a compelling indication for older individuals receiving antihypertensive treatment.